Cargando…

Lyophilized Fecal Microbiota Transplantation Capsules for Recurrent Clostridium difficile Infection

BACKGROUND: Fecal microbiota (FM) transplantation (FMT) is a highly effective treatment of recurrent C. difficile infection (rCDI). We have published data showing efficacy of fresh, frozen and lyophilized donor microbiota administered by colonoscopy. Most groups are moving toward use of frozen produ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dupont, Hebert, Jiang, Zhi-Dong, Alexander, Ashley, Ajami, Nadim, Petrosino, Joseph F, DuPont, Andrew W, Ke, Shi, Jun, Goo, Hanis, Craig
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631149/ http://dx.doi.org/10.1093/ofid/ofx163.943

Ejemplares similares

Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial
por: Jiang, Zhi-Dong, et al.
Publicado: (2018)

Fecal Microbiota Transplantation by Freeze-Dried Oral Capsules for Recurrent Clostridium difficile Infection
por: Hecker, Michelle T., et al.
Publicado: (2016)

Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
por: Youngster, Ilan, et al.
Publicado: (2016)

Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection
por: Hirsch, Bruce E, et al.
Publicado: (2015)

1798 Oral, Frozen Fecal Microbiota Capsules for Relapsing Clostridium difficile Infection
por: Youngster, Ilan, et al.
Publicado: (2014)

Safety and efficacy of fecal microbiota transplantation to treat and prevent recurrent Clostridioides difficile in cancer patients
por: Ali, Hiba, et al.
Publicado: (2021)

Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Song, Yang, et al.
Publicado: (2013)

Clostridium difficile Modulates the Gut Microbiota by Inducing the Production of Indole, an Interkingdom Signaling and Antimicrobial Molecule
por: Darkoh, Charles, et al.
Publicado: (2019)

Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results
por: Reigadas, Elena, et al.
Publicado: (2018)

Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation
por: Staley, Christopher, et al.
Publicado: (2018)

Fecal Microbiota Transplant in Recurrent Clostridium Difficile Infections: A Systematic Review
por: Gupta, Kunal, et al.
Publicado: (2022)

Correction: Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Publicado: (2014)

Prospective, Open-label Trial to Evaluate Efficacy of Lyophilized Fecal Microbiota Transplantation for Treatment of Recurrent C. difficile Infection
por: Goldeh, Peyman, et al.
Publicado: (2017)

Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
por: Hussam, Dina, et al.
Publicado: (2017)

1694. Successful Gut Decolonization of Extended-Spectrum β-lactamase Producing Klebsiella pneumoniae Using Oral Lyophilized Fecal Microbiota Transplant (FMT) in a Woman with Recurrent Urinary Tract Infections
por: Bier, Naomi, et al.
Publicado: (2020)

Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity
por: Carlucci, Christian, et al.
Publicado: (2016)

Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
por: Nanki, Kosaku, et al.
Publicado: (2018)

Engraftment and Augmentation of Microbiome Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Lee, Christine, et al.
Publicado: (2017)

Fecal Microbiota Transplantation in Recurrent Clostridium Difficile Infection: Is it Superior to Other Conventional Methods?
por: Lin, Zayar, et al.
Publicado: (2020)

Fecal Transplantation for the Treatment of Recurrent Clostridium Difficile Infection
por: Karadsheh, Zeid, et al.
Publicado: (2013)

Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection
por: Haifer, Craig, et al.
Publicado: (2021)

Accessory Gene Regulator-1 Locus Is Essential for Virulence and Pathogenesis of Clostridium difficile
por: Darkoh, Charles, et al.
Publicado: (2016)

Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection
por: Zellmer, Caroline, et al.
Publicado: (2016)

Toxin Synthesis by Clostridium difficile Is Regulated through Quorum Signaling
por: Darkoh, Charles, et al.
Publicado: (2015)

Is a Single Fecal Microbiota Transplant a Promising Treatment for Recurrent Clostridium difficile Infection?
por: Hota, Susy S, et al.
Publicado: (2018)

Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?
por: Olmedo, Maria, et al.
Publicado: (2019)

508. High Rates of Cure and Long-Term Symptom Resolution With Both Capsule and Lower Gastrointestinal Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Shull, Hannah, et al.
Publicado: (2018)

Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation
por: Staley, Christopher, et al.
Publicado: (2016)

Bile Salt Inhibition of Host Cell Damage by Clostridium Difficile Toxins
por: Darkoh, Charles, et al.
Publicado: (2013)

Antimicrobial Resistance Gene Acquisition and Depletion Following Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
por: Leung, Victor, et al.
Publicado: (2018)

Cost-Effectiveness of Fecal Microbiota Transplantation in the Treatment of Recurrent Clostridium Difficile Infection: A Literature Review
por: Arbel, Leor T, et al.
Publicado: (2017)

Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
por: Fareed, Shaaz, et al.
Publicado: (2018)

Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection
por: Li, Xiaolu, et al.
Publicado: (2018)

Fecal microbiota transplantation in recurrent Clostridium difficile infection: A retrospective single‐center chart review
por: Kim, Pamela, et al.
Publicado: (2018)

1122. Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients With recurrent Clostridium difficile Infection (CDI)
por: Hassoun, Ali, et al.
Publicado: (2018)

Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection
por: Kim, Kyeong Ok, et al.
Publicado: (2019)

Treatment of relapsing Clostridium difficile infection using fecal microbiota transplantation
por: Pathak, Rahul, et al.
Publicado: (2013)

Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond
por: Borody, Thomas J., et al.
Publicado: (2015)

Fecal microbiota transplantation for Clostridium difficile infection in patients with ileal pouches
por: Lan, Nan, et al.
Publicado: (2017)

Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation
por: DuPont, Herbert L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8demeb8k65u8hjhi70350k7lsm